Heterogeneity in β0thalassemia from Algeria: Genetic, clinical and molecular studies
✍ Scribed by Mériem Belhani; F. Morlé; P. Colonna; Jacqueline Godet
- Publisher
- Springer
- Year
- 1980
- Tongue
- English
- Weight
- 537 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
✦ Synopsis
Six Algerian patients with beta 0 thalassemia are presented, in addition to the two patients already reported (Godet et al., 1977). Family studies indicate that all the patients had homozygous beta thalassemia characterized by absence of beta globin chain synthesis in peripheral blood. The clinical severity varies from one family to the other and within the same family, from typical Cooley's anemia to thalassemia intermedia and appears to be related to the child death rate observed in each family. The gamma/alpha biosynthetic ratio was 0.36-0.40 in seven patients and 0.2 in the most seriously affected patient. The mRNA beta content in peripheral reticulocytes was less than 1.5% of mRNA alpha in seven patients and 13.3% in one patient. These results indicate that Algerians homozygous for beta 0 thalassemia are heterozygous at the clinical, biochemical and molecular levels.
📜 SIMILAR VOLUMES
Hereditary cancer represents approximately 5-10% of the total cancer burden and may account for 60,000 to 120,000 new cancer occurrences this year in the United States. New developments in molecular genetics and the cloning of cancer-prone genes have intensely fueled interest in dealing with heredit